Recent BTAI News
- BioXcel Therapeutics Announces Closing of $8.0 Million Registered Direct Offering • GlobeNewswire Inc. • 03/11/2026 08:20:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/11/2026 12:09:22 PM
- BioXcel Therapeutics Announces Approximately $8.0 Million Registered Direct Offering • GlobeNewswire Inc. • 03/10/2026 06:36:00 PM
- BioXcel posts encouraging Phase 2 results for opioid withdrawal therapy BXCL501 • IH Market News • 03/05/2026 02:53:56 PM
- BioXcel Therapeutics Announces Positive Phase 2 Topline Results from Columbia University-Led Study of BXCL501 for Treatment of Opioid Withdrawal • GlobeNewswire Inc. • 03/05/2026 12:00:00 PM
- BioXcel Therapeutics to Host Virtual Roundtable Featuring Leading Medical Experts Addressing Latest Developments in Treatment of Acute Agitation in Alzheimer’s Dementia • GlobeNewswire Inc. • 02/19/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2026 12:05:34 PM
- BioXcel Therapeutics Completes Market Opportunity Assessment and Advances Commercialization Plans for IGALMI® in the At-Home Setting • GlobeNewswire Inc. • 02/12/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2026 10:00:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/20/2026 12:00:40 PM
- BioXcel Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for IGALMI® Label Expansion in the At-Home Setting • GlobeNewswire Inc. • 01/20/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 12:09:53 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 12:01:13 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 12:02:13 PM
- BioXcel Therapeutics Expands Leadership Team to Prepare for Launch of IGALMI® in the At-Home Setting • GlobeNewswire Inc. • 01/12/2026 12:00:00 PM
- BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI® • GlobeNewswire Inc. • 01/07/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 01:00:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/16/2025 01:02:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/16/2025 01:00:15 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2025 09:30:34 PM
- Award-Winning Journalist Anjalee Khemlani to Host Virtual Roundtable with Leading Medical Experts to Discuss Latest Developments in Treating Acute Agitation Related to Neuropsychiatric Conditions • GlobeNewswire Inc. • 12/03/2025 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 11/12/2025 10:05:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/12/2025 10:00:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 02:01:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:11:00 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
